Larson Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.8K Buy
+1,808
New +$12.5K ﹤0.01% 2340
2025
Q1
– Sell
-2,880
Closed -$15.7K – 3160
2024
Q4
$15.7K Buy
2,880
+1,477
+105% +$9.5K ﹤0.01% 1311
2024
Q3
$11.7K Buy
+1,403
New +$12.1K ﹤0.01% 1422

Other funds holding MRVI

Larson Financial Group's MRVI Position: Q3 2026 in Review

Larson Financial Group opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 1,808 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #2340 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in MRVI as recently as Q4 2024.

Larson Financial Group first reported a position in MRVI in Q3 2024 and has held it in 3 quarters since. The position peaked at $15.7K in Q4 2024. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Larson Financial Group held 1,808 shares of Maravai LifeSciences worth $13.8K as of Q3 2026.
  • Maravai LifeSciences was a new Larson Financial Group position in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2340 holding.
  • Larson Financial Group first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 3 quarters since.
  • Larson Financial Group's Maravai LifeSciences position peaked at $15.7K in Q4 2024.
  • 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.